AlphaMadera's AlphaVal page computes TransUnion's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag TRU as undervalued, fairly valued, or overvalued.

What is TransUnion's fair value?

Fair value for TRU is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value TRU?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from TRU's most recent reported fundamentals.

TRU - TransUnion

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $92.56 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Moderate

Trading 20.7% above fair value

Current Price $75.02

Bear Case $36.27 51.7% downside ($36.27 - $75.02) / $75.02 = -51.7% 7% stage 1 growth, 12% discount

Fair Value $62.15 17.2% downside ($62.15 - $75.02) / $75.02 = -17.2% 12% stage 1 growth, 12% discount

Bull Case $88.71 18.2% upside ($88.71 - $75.02) / $75.02 = 18.2% 15% stage 1 growth, 12% discount

Adjust Assumptions

DCF Stage 1 Growth Rate

11.9%

Discount Rate (WACC)

12.0%

Terminal Growth Rate

3.0%

Key Value Driver

FCF growth rate (12% base case)

Terminal Value % of EV 36%

Implied Market Multiple 28.4x

Market is pricing in (growth) 15.6% vs our 11.9% base

Plain-Language Summary

Our base-case estimate uses a two-stage discounted cash flow model based on free cash flow. We then blend that result with the average analyst price target of $92.56 from 27 analysts, using a 25% weight on analyst consensus. That produces an estimated intrinsic value of $62.15 per share.

Warnings

ℹ Wall Street's average price target is $92.56 (from 27 analysts). Our estimate is 44% below the consensus -- consider that gap carefully.

Key Risks

P/E alone misleads — earnings depressed by growth investment
Cyclical or commodity businesses may be misclassified as platforms
Terminal value dominance suggests sensitivity to long-run assumptions